- Tech Times
- Posts
- Nvidia’s New Chapter, Hope for Lupus and Celiac Patients
Nvidia’s New Chapter, Hope for Lupus and Celiac Patients
Ayden Noh
November 12, 2026
Good morning, friend. The heart of today’s news is a leadership earthquake at Nvidia, but there’s also real hope coming out of the medical labs.
The Top Story
Nvidia After Jensen Huang: Who Holds the Wheel Now?
Nvidia is reeling after Jensen Huang’s resignation, with shares sliding as CFO Colette Kress takes the interim CEO seat while keeping her finance job. The timing is rough, since earnings are just around the corner. Another report says the board had been weighing his future before the news broke, so expect plenty of questions in the days ahead.
Read More
Quick Hits
A Pill for Gluten Damage? Teva’s celiac drug became the first to block gluten damage in a clinical trial, a real step forward for people who’ve avoided bread for years.
Remission Without the Daily Meds: Three new studies found CAR-T cell therapy gave drug-free remissions to people with treatment-resistant lupus and arthritis.
AI
TSMC Bets Big on Anthropic and OpenAI: The chipmaker is putting $1B into the two AI labs, raising fresh questions about where the industry goes next. Read More
The Sleeper Agent Inside the Model: Microsoft researchers showed that editing fewer than ten neurons can hide an AI agent’s attack until a certain date arrives.
No Bots Allowed at the Gate: United Airlines will block AI agents from booking flights on its site and through third parties, and the reason may go beyond security.
Reviews
Big Screen, Fair Price: The XGIMI HORIZON 30 Pro earns a nod as the best RGB laser projector value at $1,899, though our reviewer flags a data-privacy caveat.
A Gym That Folds Away: The INNODIGYM OMNI X1 Pro packs digital resistance, adjustable cables and a 21.5-inch touchscreen into a quiet home gym that tucks out of sight between workouts.